Found: 31
Select item for more details and to access through your institution.
Predictive factors for lymph node metastasis in papillary thyroid cancer patients undergoing neck dissection: insights from a large cohort study.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1447903
- By:
- Publication type:
- Article
Inhibition of BRAF Sensitizes Thyroid Carcinoma to Immunotherapy by Enhancing tsMHCII-mediated Immune Recognition.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Partial preservation of the normal thyroid gland based on tumor diameter may be possible in small medullary thyroid carcinoma: a two-center 15-year retrospective study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1216394
- By:
- Publication type:
- Article
Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway.
- Published in:
- Cell & Bioscience, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13578-022-00934-z
- By:
- Publication type:
- Article
Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 59, doi. 10.1007/s10147-019-01522-x
- By:
- Publication type:
- Article
Rtfc (4931414P19Rik) Regulates in vitro Thyroid Differentiation and in vivo Thyroid Function.
- Published in:
- Scientific Reports, 2017, p. 43396, doi. 10.1038/srep43396
- By:
- Publication type:
- Article
Cancer‐cell‐secreted extracellular vesicles target p53 to impair mitochondrial function in muscle.
- Published in:
- EMBO Reports, 2023, v. 24, n. 9, p. 1, doi. 10.15252/embr.202256464
- By:
- Publication type:
- Article
Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma.
- Published in:
- Thyroid, 2019, v. 29, n. 6, p. 809, doi. 10.1089/thy.2018.0550
- By:
- Publication type:
- Article
SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2‐Mediated Chromatin Remodeling.
- Published in:
- Advanced Science, 2024, v. 11, n. 32, p. 1, doi. 10.1002/advs.202401712
- By:
- Publication type:
- Article
Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 1, p. 105, doi. 10.20892/j.issn.2095-3941.2020.0098
- By:
- Publication type:
- Article
Surgery and Radioactive Iodine Therapeutic Strategy for Patients Greater Than 60 Years of Age with Differentiated Thyroid Cancer.
- Published in:
- Journal of Healthcare Engineering, 2022, p. 1, doi. 10.1155/2022/4348396
- By:
- Publication type:
- Article
Lnc-SNHG5 Promoted Hepatocellular Carcinoma Progression Through the RPS3-NFκB Pathway.
- Published in:
- International Journal of General Medicine, 2023, v. 16, p. 5651, doi. 10.2147/IJGM.S442937
- By:
- Publication type:
- Article
PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause.
- Published in:
- International Journal of Biological Sciences, 2023, v. 19, n. 12, p. 3970, doi. 10.7150/ijbs.81895
- By:
- Publication type:
- Article
An Inducible CRISPR‐dCas9‐Based Transcriptional Repression System for Cancer Therapy.
- Published in:
- Small Methods, 2024, v. 8, n. 8, p. 1, doi. 10.1002/smtd.202301310
- By:
- Publication type:
- Article
Targeting Aurora-A inhibits tumor progression and sensitizes thyroid carcinoma to Sorafenib by decreasing PFKFB3-mediated glycolysis.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 3, p. 1, doi. 10.1038/s41419-023-05709-z
- By:
- Publication type:
- Article
Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 2, p. 1, doi. 10.1038/s41419-022-04550-0
- By:
- Publication type:
- Article
LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 4, p. 1, doi. 10.1038/s41419-021-03641-8
- By:
- Publication type:
- Article
Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.15025
- By:
- Publication type:
- Article
To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments.
- Published in:
- Disease Markers, 2022, p. 1, doi. 10.1155/2022/9541080
- By:
- Publication type:
- Article
Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic-associated molecular subtypes and genomic mutations.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1224828
- By:
- Publication type:
- Article
Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.1008301
- By:
- Publication type:
- Article
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles.
- Published in:
- Oncology Letters, 2019, v. 18, n. 6, p. 6670, doi. 10.3892/ol.2019.11059
- By:
- Publication type:
- Article
Integrated microRNA‑mRNA analyses of distinct expression profiles in follicular thyroid tumors.
- Published in:
- Oncology Letters, 2017, v. 14, n. 6, p. 7153, doi. 10.3892/ol.2017.7146
- By:
- Publication type:
- Article
Diagnosis and treatment of ectopic thyroid carcinoma: A case report and literature review.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway.
- Published in:
- Theranostics, 2022, v. 12, n. 4, p. 1500, doi. 10.7150/thno.66142
- By:
- Publication type:
- Article
Breast cancer cell-secreted miR-199b-5p hijacks neurometabolic coupling to promote brain metastasis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48740-0
- By:
- Publication type:
- Article
High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 1309, doi. 10.2147/OTT.S184560
- By:
- Publication type:
- Article
Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00217
- By:
- Publication type:
- Article
Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 9, p. 1592, doi. 10.7150/jca.83853
- By:
- Publication type:
- Article
The survival outcomes of prophylactic lateral neck dissection for medullary thyroid carcinoma, a retrospective cohort study.
- Published in:
- Clinical Otolaryngology, 2023, v. 48, n. 5, p. 734, doi. 10.1111/coa.14053
- By:
- Publication type:
- Article